Tüdőrák: vizsgálatok itt: Thaiföld

32 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  Where

  Bang Kapi, Bangkok, Bangkoknoi, Hat Yai, Muang, Pathum Wan

  Életkor

  18 év and over

  People

  360 worldwide

  Run by

  Taiho Oncology, Inc.

  See details and how to joinNCT07128199 · EU 2025-521775-31-00
• 2/3. fázisTaking people
  Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  Where

  Bangkok, Mueng, Songkhla

  Életkor

  18 év and over

  People

  500 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07100080
• 3. fázisTaking people
  Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  Where

  Bangkok, Chiang Mai, Din Daeng, Ongkharak

  Életkor

  18 év and over

  People

  450 worldwide

  Run by

  Nuvalent Inc.

  See details and how to joinNCT06765109 · EU 2024-517553-26-00
• 3. fázisTaking people
  Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

  Where

  Bangkok, Dusit, Hat Yai, Udon Thani

  Életkor

  18 év and over

  People

  582 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06350097 · EU 2023-509883-89-00
• 1. fázisTaking people
  Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

  Where

  Bangkok, Hat Yai, Khon Kaen, Muang

  Életkor

  18 év and over

  People

  304 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT04686305 · EU 2023-504949-31-00
• 1/2. fázisTaking people
  A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC

  Where

  Ratchathewi

  Életkor

  18 év and over

  People

  150 worldwide

  Run by

  J Ints Bio

  See details and how to joinNCT05394831
• No phaseTaking people
  Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

  Where

  Bangkok

  Életkor

  18 év and over

  People

  104

  Run by

  Mahidol University

  See details and how to joinNCT06786468